Kyiv, Ukraine

Iryna Yu Slavchenko

This inventor holds 3 USPTO granted patents. Top assignee: Phage Biotechnology Corporation. Active years: 2003-2004.


Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Iryna Yu Slavchenko: Innovator in Biotechnological Advancements

Introduction

Iryna Yu Slavchenko is a prominent inventor based in Kyiv, Ukraine. She has made significant contributions to the field of biotechnology, particularly in the production of biologically active proteins and peptides. With a total of 3 patents to her name, her work is paving the way for advancements in biopharmaceuticals.

Latest Patents

One of her latest patents is focused on the phage-dependent super-production of biologically active proteins and peptides. This invention describes a method for enhancing the production of these proteins in bacterial cells by infecting them with bacteriophage λ. The process involves cultivating the producer strain cells under specific conditions that delay the lytic development of the phage, allowing for the accumulation of biologically active proteins in the culture medium. Another patent also addresses a similar method, emphasizing the use of a T7 polymerase promoter to control the expression of targeted genes, further enhancing the synthesis of the desired proteins.

Career Highlights

Iryna is currently associated with Phage Biotechnology Corporation, where she continues to innovate and develop new biotechnological methods. Her expertise in the field has positioned her as a key player in advancing biopharmaceutical production techniques.

Collaborations

Iryna collaborates with notable colleagues such as Vitaliy A Kordyum and Svitlana I Chernykh, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Iryna Yu Slavchenko's work in biotechnology exemplifies the impact of innovative thinking on the production of biologically active substances. Her patents reflect a commitment to enhancing biopharmaceutical processes, making her a significant figure in her field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…